Koyfin Home > Directory > Health Care > Nymox Pharm Corp > Net Income

Nymox Pharm Corp Net Income Chart (NYMX)

Nymox Pharm Corp annual/quarterly Net Income from 2010 to 2020. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Nymox Pharm Corp Net Income for the quarter ending June 06, 2020 was $-3m a 16.29% decrease of 0m year over year
  • Nymox Pharm Corp Net Income for the last 12 months ending June 06, 2020 was $-11m a -23.28% increase of 2m year over year
  • Nymox Pharm Corp Annual Net Income for 2019 was $-13m a 19.51% decrease of -3m from 2018
  • Nymox Pharm Corp Annual Net Income for 2018 was $-11m a -26.76% increase of 3m from 2017
  • Nymox Pharm Corp Annual Net Income for 2017 was $-13m a 2.38% decrease of 0m from 2016
Other Income Statement Metrics:
  • Nymox Pharm Corp EBITDA for the quarter ending September 09, 2018 was $-3m a -17.77% increase of 0m year over year
  • Nymox Pharm Corp Total Revenue for the quarter ending September 09, 2018 was $0m a -163.24% decrease of 0m year over year
View Chart On Koyfin

Quarterly NYMX Net Income Data

06/2020$-3m
03/2020$-3m
12/2019$-3m
09/2019$-2m
06/2019$-5m
03/2019$-3m
12/2018$-3m
09/2018$-3m
06/2018$-2m
03/2018$-3m

Annual NYMX Net Income Data

2019$-13m
2018$-11m
2017$-13m
2016$-13m
2015$-18m
2014$-5m
2013$-5m
2012$-8m
2011$-10m
2010$-7m